Report period | 2019 | 2020 | 2021 | 2022 | 2023 | Q3 24 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, $ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
PBH:US | Prestige Consumer Healthcare, Inc. | Common share | - | US74112D1019 | $71.81 |
Company name | Prestige Consumer Healthcare |
---|---|
Sector | Health Care / Health Care Equipment & Services / Health Care Providers & Services / Health Care Distributors |
Business address | 660 WHITE PLAINS RD. TARRYTOWN NY 10591 (914) 524-6800 |
Mailing address | 660 WHITE PLAINS RD. TARRYTOWN NY 10591 |
Website | www.prestigebrands.com |
Information disclosure | www.sec.gov |